A Medical Device Daily
Clinical Technology Advisors (CTA; Boston), a provider of medication adherence and patient compliance solutions, and SIMpill (Pty) Ltd. (Cape Town, South Africa), which focuses on wireless medication compliance technologies, have entered into an exclusive distribution agreement.
The agreement allows CTA to offer the SIMpill medication adherence system to the North American market, effective immediately. CTA's initial focus will be the deployment of the system in the clinical trials and disease management environments.
SIMpill is a patent-pending system designed to track, manage, and improve a patient's medication adherence in real-time. The “reminder device” has had success in South Africa with patients self-managing HIV/AIDS and tuberculosis medications, the company said.
CTA said it would continue to introduce the system to clinical trials and disease management sponsors across all chronic medical conditions.
The system consists of a “durable, tamperproof” pill bottle attached to a SIMpill module containing the components of a wireless quad-band GSM/GPRS cell phone. The module is programmed with multiple time windows based on the dosing schedule of the drug.
When the patient opens the bottle, the module automatically sends an SMS message to a central computer system indicating that a dose has been taken. If the SMS message is not received within the first programmed time window, an outgoing text message is sent to the patient's cell phone (and/or e-mail) reminding him or her to take their medication.
If the bottle is not opened within the next programmed time window, a text message can be sent to a designated caregiver or researcher, who can then contact the patient by some other means.
In addition, as SMS events are captured, approved healthcare managers can track the patient's medication adherence in real time using SIMpill's web-based reporting tool.